Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Leisha J. Richardson is active.

Publication


Featured researches published by Leisha J. Richardson.


American Journal of Tropical Medicine and Hygiene | 2011

Acute Post-Streptococcal Glomerulonephritis in the Northern Territory of Australia: A Review of 16 Years Data and Comparison with the Literature

Catherine S. Marshall; Allen C. Cheng; Peter Markey; Rebecca J. Towers; Leisha J. Richardson; Peter K. Fagan; Lesley Scott; Vicki Krause; Bart J. Currie

Data relating to acute post-streptococcal glomerulonephritis (APSGN) from the notifiable diseases surveillance system in the Northern Territory of Australia was extracted and analyzed. Isolates of Streptococcus pyogenes from confirmed cases were emm sequence typed. From 1991 to July 2008, there were 415 confirmed cases and 23 probable cases of APSGN notified. Four hundred fifteen (94.7%) of these were Indigenous Australians and 428 (97.7%) were people living in remote or very remote locations. The median age of cases was 7 years (range 0-54). The incidence of confirmed cases was 12.5/100,000 person-years, with an incidence in Indigenous Australian children younger than 15 years of age of 94.3 cases/100,000 person-years. The overall rate ratio of confirmed cases in Indigenous Australians to non-Indigenous Australians was 53.6 (95% confidence interval 32.6-94.8). Outbreaks of disease across multiple communities occurred in 1995 (N = 68), 2000 (N = 55), and 2005 (N = 87 [confirmed cases]). Various emm types of S. pyogenes were isolated from cases of APSGN including some types not previously recognized to be nephritogenic. The widespread outbreak in 2005 was caused by emm55.0 S. pyogenes. Acute post-streptococcal glomerulonephritis continues to occur in remote Indigenous communities in Australia at rates comparable to or higher than those estimated in developing countries. Improvements in preventative and outbreak control strategies are needed.


PLOS ONE | 2012

Characterization of ceftazidime resistance mechanisms in clinical isolates of Burkholderia pseudomallei from Australia.

Derek S. Sarovich; Erin P. Price; Alex T. von Schulze; James M. Cook; Mark Mayo; Lindsey M. Watson; Leisha J. Richardson; Meagan L. Seymour; Apichai Tuanyok; David M. Engelthaler; Talima Pearson; Sharon J. Peacock; Bart J. Currie; Paul Keim; David M. Wagner

Burkholderia pseudomallei is a Gram-negative bacterium that causes the serious human disease, melioidosis. There is no vaccine against melioidosis and it can be fatal if not treated with a specific antibiotic regimen, which typically includes the third-generation cephalosporin, ceftazidime (CAZ). There have been several resistance mechanisms described for B. pseudomallei, of which the best described are amino acid changes that alter substrate specificity in the highly conserved class A β-lactamase, PenA. In the current study, we sequenced penA from isolates sequentially derived from two melioidosis patients with wild-type (1.5 µg/mL) and, subsequently, resistant (16 or ≥256 µg/mL) CAZ phenotypes. We identified two single-nucleotide polymorphisms (SNPs) that directly increased CAZ hydrolysis. One SNP caused an amino acid substitution (C69Y) near the active site of PenA, whereas a second novel SNP was found within the penA promoter region. In both instances, the CAZ resistance phenotype corresponded directly with the SNP genotype. Interestingly, these SNPs appeared after infection and under selection from CAZ chemotherapy. Through heterologous cloning and expression, and subsequent allelic exchange in the native bacterium, we confirmed the role of penA in generating both low-level and high-level CAZ resistance in these clinical isolates. Similar to previous studies, the amino acid substitution altered substrate specificity to other β-lactams, suggesting a potential fitness cost associated with this mutation, a finding that could be exploited to improve therapeutic outcomes in patients harboring CAZ resistant B. pseudomallei. Our study is the first to functionally characterize CAZ resistance in clinical isolates of B. pseudomallei and to provide proven and clinically relevant signatures for monitoring the development of antibiotic resistance in this important pathogen.


Environmental Microbiology | 2012

Out of the ground: aerial and exotic habitats of the melioidosis bacterium Burkholderia pseudomallei in grasses in Australia

Mirjam Kaestli; Michael Schmid; Mark Mayo; Michael Rothballer; Glenda Harrington; Leisha J. Richardson; Audrey A. Hill; Jason Hill; Apichai Tuanyok; Paul Keim; Anton Hartmann; Bart J. Currie

Melioidosis is an emerging infectious disease of humans and animals in the tropics caused by the soil bacterium Burkholderia pseudomallei. Despite high fatality rates, the ecology of B.pseudomallei remains unclear. We used a combination of field and laboratory studies to investigate B.pseudomallei colonization of native and exotic grasses in northern Australia. Multivariable and spatial analyses were performed to determine significant predictors for B.pseudomallei occurrence in plants and soil collected longitudinally from field sites. In plant inoculation experiments, the impact of B.pseudomallei upon these grasses was studied and the bacterial load semi-quantified. Fluorescence in situ hybridization and confocal laser scanning microscopy were performed to localize the bacteria in plants. Burkholderia pseudomallei was found to inhabit not only the rhizosphere and roots but also aerial parts of specific grasses. This raises questions about the potential spread of B.pseudomallei by grazing animals whose droppings were found to be positive for these bacteria. In particular, B.pseudomallei readily colonized exotic grasses introduced to Australia for pasture. The ongoing spread of these introduced grasses creates new habitats suitable for B.pseudomallei survival and may be an important factor in the evolving epidemiology of melioidosis seen both in northern Australia and elsewhere globally.


Journal of Microbiological Methods | 2012

Towards a rapid molecular diagnostic for melioidosis: Comparison of DNA extraction methods from clinical specimens.

Leisha J. Richardson; Mirjam Kaestli; Mark Mayo; Jolene Bowers; Apichai Tuanyok; James M. Schupp; David M. Engelthaler; David M. Wagner; Paul Keim; Bart J. Currie

Optimising DNA extraction from clinical samples for Burkholderia pseudomallei Type III secretion system real-time PCR in suspected melioidosis patients confirmed that urine and sputum are useful diagnostic samples. Direct testing on blood remains problematic; testing DNA extracted from plasma was superior to DNA from whole blood or buffy coat.


Journal of Clinical Microbiology | 2012

Comparison of TaqMan PCR Assays for Detection of the Melioidosis Agent Burkholderia pseudomallei in Clinical Specimens

Mirjam Kaestli; Leisha J. Richardson; Rebecca E. Colman; Apichai Tuanyok; Erin P. Price; Jolene Bowers; Mark Mayo; Erin Kelley; Meagan L. Seymour; Derek S. Sarovich; Talima Pearson; David M. Engelthaler; David M. Wagner; Paul Keim; James M. Schupp; Bart J. Currie

ABSTRACT Melioidosis is an emerging infectious disease caused by the soil bacterium Burkholderia pseudomallei. In diagnostic and forensic settings, molecular detection assays need not only high sensitivity with low limits of detection but also high specificity. In a direct comparison of published and newly developed TaqMan PCR assays, we found the TTS1-orf2 assay to be superior in detecting B. pseudomallei directly from clinical specimens. The YLF/BTFC multiplex assay (targeting the Yersinia-like fimbrial/Burkholderia thailandensis-like flagellum and chemotaxis region) also showed high diagnostic sensitivity and provides additional information on possible geographic origin.


PLOS ONE | 2011

High-resolution melting genotyping of Enterococcus faecium based on multilocus sequence typing derived single nucleotide polymorphisms

Steven Y. C. Tong; Shirley Xie; Leisha J. Richardson; Susan A. Ballard; Farshid Dakh; Elizabeth A. Grabsch; Lindsay Grayson; Benjamin P. Howden; Paul D. R. Johnson; Philip M. Giffard

We have developed a single nucleotide polymorphism (SNP) nucleated high-resolution melting (HRM) technique to genotype Enterococcus faecium. Eight SNPs were derived from the E. faecium multilocus sequence typing (MLST) database and amplified fragments containing these SNPs were interrogated by HRM. We tested the HRM genotyping scheme on 85 E. faecium bloodstream isolates and compared the results with MLST, pulsed-field gel electrophoresis (PFGE) and an allele specific real-time PCR (AS kinetic PCR) SNP typing method. In silico analysis based on predicted HRM curves according to the G+C content of each fragment for all 567 sequence types (STs) in the MLST database together with empiric data from the 85 isolates demonstrated that HRM analysis resolves E. faecium into 231 “melting types” (MelTs) and provides a Simpsons Index of Diversity (D) of 0.991 with respect to MLST. This is a significant improvement on the AS kinetic PCR SNP typing scheme that resolves 61 SNP types with D of 0.95. The MelTs were concordant with the known ST of the isolates. For the 85 isolates, there were 13 PFGE patterns, 17 STs, 14 MelTs and eight SNP types. There was excellent concordance between PFGE, MLST and MelTs with Adjusted Rand Indices of PFGE to MelT 0.936 and ST to MelT 0.973. In conclusion, this HRM based method appears rapid and reproducible. The results are concordant with MLST and the MLST based population structure.


Clinical Microbiology and Infection | 2011

Preliminary validation of a novel high-resolution melt-based typing method based on the multilocus sequence typing scheme of Streptococcus pyogenes

Leisha J. Richardson; Steven Y. C. Tong; Rebecca J. Towers; Flavia Huygens; Karen F. McGregor; Peter K. Fagan; Bart J. Currie; Jonathan R. Carapetis; Philip M. Giffard

The major limitation of current typing methods for Streptococcus pyogenes, such as emm sequence typing and T typing, is that these are based on regions subject to considerable selective pressure. Multilocus sequence typing (MLST) is a better indicator of the genetic backbone of a strain but is not widely used due to high costs. The objective of this study was to develop a robust and cost-effective alternative to S. pyogenes MLST. A 10-member single nucleotide polymorphism (SNP) set that provides a Simpsons Index of Diversity (D) of 0.99 with respect to the S. pyogenes MLST database was derived. A typing format involving high-resolution melting (HRM) analysis of small fragments nucleated by each of the resolution-optimized SNPs was developed. The fragments were 59-119 bp in size and, based on differences in G+C content, were predicted to generate three to six resolvable HRM curves. The combination of curves across each of the 10 fragments can be used to generate a melt type (MelT) for each sequence type (ST). The 525 STs currently in the S. pyogenes MLST database are predicted to resolve into 298 distinct MelTs and the method is calculated to provide a D of 0.996 against the MLST database. The MelTs are concordant with the S. pyogenes population structure. To validate the method we examined clinical isolates of S. pyogenes of 70 STs. Curves were generated as predicted by G+C content discriminating the 70 STs into 65 distinct MelTs.


American Journal of Tropical Medicine and Hygiene | 2011

Molecular characterization of clinical Burkholderia pseudomallei isolates from India.

Chiranjay Mukhopadhyay; Mirjam Kaestli; Ke Vandana; Krishna Sushma; Mark Mayo; Leisha J. Richardson; Apichai Tuanyok; Paul Keim; Daniel Godoy; Brian G. Spratt; Bart J. Currie

Multilocus sequence typing of seven isolates of Burkholderia pseudomallei from India showed considerable diversity, with six different sequence types. Possible dissemination of melioidosis by historical trading routes is supported by links to strains from Southeast Asia, China, and Africa and the presence of the Burkholderia mallei allele of the bimA gene.


Emerging Infectious Diseases | 2011

Melioidosis in birds and Burkholderia pseudomallei dispersal Australia

Vanya R. S. Hampton; Mirjam Kaestli; Mark Mayo; Jodie Low Choy; Glenda Harrington; Leisha J. Richardson; Suresh Benedict; Richard A. Noske; Stephen T. Garnett; Daniel Godoy; Brian G. Spratt; Bart J. Currie

To the Editor: Melioidosis is an emerging infectious disease of humans and animals caused by the gram-negative bacterium Burkholderia pseudomallei, which inhabits soil and surface water in the disease-endemic regions of Southeast Asia and northern Australia (1). The aim of this study was to assess the potential for birds to spread B. pseudomallei. Birds are known carriers of various human pathogens, including influenza viruses, West Nile virus, Campylobacter jejuni, and antimicrobial drug–resistant Escherichia coli (2).


American Journal of Tropical Medicine and Hygiene | 2013

Melioidosis as a consequence of sporting activity.

Audrey A. Hill; Mark Mayo; Mirjam Kaestli; Erin P. Price; Leisha J. Richardson; Daniel Godoy; Brian G. Spratt; Bart J. Currie

In the tropical city of Darwin, Northern Territory, Australia, dry season soil sampling cultured Burkholderia pseudomallei from 7 (70%) of 10 sports fields. However, during the 23 years of the Darwin Prospective Melioidosis Study, only 5 (0.6%) of 785 melioidosis cases have been attributed to infection from sports fields. In one soccer player with cutaneous melioidosis, B. pseudomallei cultured from the player was identical by multilocus sequence typing and multilocus variable-number tandem repeat analysis with an isolate recovered from soil at the location on the sports field where he was injured. Melioidosis is uncommon in otherwise healthy sports persons in melioidosis-endemic regions but still needs consideration in persons with abrasion injuries that involve contact with soil.

Collaboration


Dive into the Leisha J. Richardson's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Mark Mayo

Charles Darwin University

View shared research outputs
Top Co-Authors

Avatar

Mirjam Kaestli

Charles Darwin University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Erin P. Price

University of the Sunshine Coast

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Daniel Godoy

Imperial College London

View shared research outputs
Top Co-Authors

Avatar

David M. Engelthaler

Translational Genomics Research Institute

View shared research outputs
Top Co-Authors

Avatar

Audrey A. Hill

Charles Darwin University

View shared research outputs
Top Co-Authors

Avatar

Derek S. Sarovich

University of the Sunshine Coast

View shared research outputs
Researchain Logo
Decentralizing Knowledge